Business Description
Sandu Pharmaceuticals Ltd
ISIN : INE751D01014
Total Employee Number:
303Compare
Compare
Traded in other countries / regions
524703.India IPO Date
1994-09-12Description
Sandu Pharmaceuticals Ltd is a pharmaceutical company. It is principally engaged in the manufacturing and sale of Ayurvedic pharmaceutical products.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 16.35 | |||||
Equity-to-Asset | 0.78 | |||||
Debt-to-Equity | 0.01 | |||||
Debt-to-EBITDA | 0.12 | |||||
Interest Coverage | 20.32 | |||||
Piotroski F-Score | 8/9 | |||||
Altman Z-Score | 3.79 | |||||
Beneish M-Score | -2.7 | |||||
WACC vs ROIC | ||||||
Growth Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 1.5 | |||||
3-Year EBITDA Growth Rate | 6.2 | |||||
3-Year EPS without NRI Growth Rate | 8 | |||||
3-Year Book Growth Rate | 3.6 |
Momentum Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 54.23 | |||||
9-Day RSI | 49.83 | |||||
14-Day RSI | 47.65 | |||||
3-1 Month Momentum % | -9.29 | |||||
6-1 Month Momentum % | 9.66 | |||||
12-1 Month Momentum % | -18.67 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 2.43 | |||||
Quick Ratio | 1.42 | |||||
Cash Ratio | 0.66 | |||||
Days Inventory | 148.03 | |||||
Days Sales Outstanding | 30.62 | |||||
Days Payable | 55.01 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 2.1 | |||||
Dividend Payout Ratio | 0.41 | |||||
3-Year Dividend Growth Rate | 2.2 | |||||
Forward Dividend Yield % | 2.63 | |||||
5-Year Yield-on-Cost % | 2.09 | |||||
Shareholder Yield % | 2.26 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 57.95 | |||||
Operating Margin % | 3.37 | |||||
Net Margin % | 2.54 | |||||
EBITDA Margin % | 4.96 | |||||
FCF Margin % | 7.75 | |||||
OCF Margin % | 8.78 | |||||
ROE % | 4.15 | |||||
ROA % | 3.15 | |||||
ROIC % | 3.31 | |||||
3-Year ROIIC % | 72.44 | |||||
ROC (Joel Greenblatt) % | 9.92 | |||||
ROCE % | 6.29 | |||||
Years of Profitability over Past 10-Year | 9 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 19.56 | |||||
PE Ratio without NRI | 19.56 | |||||
Shiller PE Ratio | 25.81 | |||||
Price-to-Owner-Earnings | 7.43 | |||||
PS Ratio | 0.55 | |||||
PB Ratio | 0.84 | |||||
Price-to-Tangible-Book | 0.84 | |||||
Price-to-Free-Cash-Flow | 6.86 | |||||
Price-to-Operating-Cash-Flow | 6.05 | |||||
EV-to-EBIT | 10.87 | |||||
EV-to-EBITDA | 8.78 | |||||
EV-to-Revenue | 0.44 | |||||
EV-to-FCF | 5.56 | |||||
Price-to-GF-Value | 0.71 | |||||
Price-to-Projected-FCF | 0.63 | |||||
Price-to-Median-PS-Value | 0.97 | |||||
Price-to-Graham-Number | 0.89 | |||||
| Price-to-Net-Current-Asset-Value | 2.8 | |||||
Earnings Yield (Greenblatt) % | 9.2 | |||||
FCF Yield % | 14.68 | |||||
Forward Rate of Return (Yacktman) % | 6.41 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Sandu Pharmaceuticals Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 696.242 | ||
| EPS (TTM) (₹) | 1.96 | ||
| Beta | 1.2614 | ||
| 3-Year Sharpe Ratio | -0.24 | ||
| 3-Year Sortino Ratio | -0.42 | ||
| Volatility % | 52.19 | ||
| 14-Day RSI | 47.65 | ||
| 14-Day ATR (₹) | 2.04231 | ||
| 20-Day SMA (₹) | 38.0515 | ||
| 12-1 Month Momentum % | -18.67 | ||
| 52-Week Range (₹) | 30 - 50.5 | ||
| Shares Outstanding (Mil) | 9.66 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 8 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Sandu Pharmaceuticals Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Sandu Pharmaceuticals Ltd Stock Events
| Event | Date | Price (₹) | ||
|---|---|---|---|---|
| INR 1.000000 Cash Dividend | 2026-09-04 | In 1 day | ||
| INR 0.800000 Cash Dividend | 2025-09-18 | 48.79 (-1.33%) | ||
| INR 0.800000 Cash Dividend | 2024-09-19 | 64.40 (-2.35%) |
Show
Entries
Sandu Pharmaceuticals Ltd Frequently Asked Questions
What is Sandu Pharmaceuticals Ltd(BOM:524703)'s stock price today?
The current price of BOM:524703 is ₹38.05. The 52 week high of BOM:524703 is ₹50.50 and 52 week low is ₹30.00.
When is next earnings date of Sandu Pharmaceuticals Ltd(BOM:524703)?
The next earnings date of Sandu Pharmaceuticals Ltd(BOM:524703) is .
Does Sandu Pharmaceuticals Ltd(BOM:524703) pay dividends? If so, how much?
The Dividend Yield %  of Sandu Pharmaceuticals Ltd(BOM:524703) is 2.1% (As of Today), Highest Dividend Payout Ratio of Sandu Pharmaceuticals Ltd(BOM:524703) was 0.5. The lowest was 0.27. And the median was 0.46. The  Forward Dividend Yield % of Sandu Pharmaceuticals Ltd(BOM:524703) is 2.63%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Sandu Pharmaceuticals Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers